Certain branded paracetamols and other over-the-counter medicines for flu-like symptoms ran out of stock in several small and large drugstores in the Philippines due to amplified demand amid the country’s soaring COVID-19 cases anew.

Philippines’ leading drug manufacturer Unilab reported a shortage of pharmacy stock, including its known and widely used brands like Biogesic, Bioflu, Neozep, and Solmux. “Some of our brands are temporarily out of stock in select drugstores due to extraordinary demand,” Unilab said in a statement. The corporation, on the other hand, promised that it is working its best to replenish its stocks as early as possible. Other major Philippine pharmaceutical companies reported the same issue, such as Zuellig Pharma and Generika. However, the Department of Trade and Industry (DTI) of the Philippines clarified that this is only the result of some delivery delays of stocks in drugstores. The agency has also ordered to impose purchase limits on the medicines to avoid panic-buying and hoarding. Additionally, together with the Philippines’ Department of Health (DOH), DTI urged Filipinos to consider buying generic drugs as alternatives since they are as effective as the branded ones. The Pharmaceutical and Healthcare Association of the Philippines (PHAP) also advised the public to buy only the needed number of medicines because of their limited shelf life or expiration dates and to be considerate of other patients who may need them more.